Confirmed Sponsorship & Exhibits
Confirmed cGvHD 2024 Sponsors & Exhibitors
Please check below the companies that supported cGvHD 2024 Symposium:
PLATINUM SPONSOR
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
In Canada, we employ over 2,000 people and invest annually 20% of our revenue in R&D. We’re also on track to deliver over $2 billion in new infrastructure investments by 2028, including two new vaccine manufacturing facilities at our Toronto Campus. Our organization URL is: https://www.sanofi.com/en/canada
Incyte is a Biopharmaceutical Company on a Mission to Solve On.
- 2,500+ Employees with operations in North America, Europe and Asia
- 1,000+ Research and clinical development employees
- 8 Approved products and ongoing clinical trials in dozens of disease areas
- 6 Consecutive years on the Science Magazine top employers list
Solve On. speaks to our relentless pursuit to find answers for patients by following the science. It inspires us to bring advances for those with unmet medical needs, regardless of the disease or size of the patient population. And it reminds us that patients are waiting. That exciting mission is Incyte. https://incyte.com/
SILVER SPONSOR
For over 30 years, Miltenyi Biotec has been a leading provider of products and services for clinical research and cell and gene therapy, enabling the delivery of new treatment options to patients with unmet medical needs. Today, over 2,500 patients are treated annually with cell products using Miltenyi Biotec technologies. We specialize in developing tailored cell processing protocols for the GMP-compliant CliniMACS Prodigy® platform, to enable closed and automated manufacture of complex cellular products such as CAR NK cells, CAR T cells, TCR-transduced T cells, and gene-modified stem cells.https://www.miltenyibiotec.com/
Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world’s leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world’s best known and most prescribed medicines and vaccines. Pfizer Inc. invested US$ 8.65 billion in 2019 globally toward developing safe and effective medicines. To learn more about Pfizer Canada, visit pfizer.ca
BRONZE SPONSOR
Innovation. Accuracy. Expertise. Speed.
When you work with us, you’re accessing over 30 years of diagnostic innovation and specialized expertise in infectious disease, pre- and post-transplant, allergy and immunology testing for immunocompromised and critical patients — plus a menu of over 3000 assays. We are passionate about providing timely, actionable diagnostic information — never losing sight of the connection between the testing we perform and the patients you serve. www.eurofins-viracor.com/clinical
SYMPOSIA SUPPORTERS
Experts at BC Children’s Hospital are world leaders in pediatric health care and are widely known for the specialized care, innovative therapies, and ground-breaking research discoveries they’re leading to improve the health outcomes of children across the province and beyond.
BC Children’s Hospital is now one of the few facilities in North America with an acute care centre, mental health facility, research institute, and rehabilitation and developmental assessment centre—all on one single campus. With this newly integrated campus, our ability to directly translate research discoveries into clinical care—and vice versa—has never been greater. BC Children’s also serves the largest geographic region of any children’s hospital in North America—almost a million square miles. The hospital offers travelling and virtual outreach clinics, as well as an expanded online telehealth program, to ensure more kids can get the care they need closer to home.
Since 1982, our Foundation has been working to inspire people and communities to join our quest and raise the bar of children’s health care. The generosity of the donor community helps to change the lives of families today—from enabling new programs that deliver compassionate care tailored to the needs of children, to purchasing the latest innovations in equipment—helping shape what child health can become—by fueling research aimed at conquering and ultimately preventing childhood diseases. Home | BC Children’s Hospital Foundation (bcchf.ca)
CSL is a global biotechnology leader that develops and delivers innovative medicines that save lives, protects public health and helps people with life-threatening medical conditions live full lives. CSL Behring
The mission of the Meredith A. Cowden Foundation is to increase the number of blood and marrow transplant survivors, to raise awareness of transplant complications and late effects, and to reduce their impact. The Meredith A. Cowden Foundation is committed to:
- Providing funding for research to prevent, treat and cure Graft vs. Host Disease (GVHD)
- Educating physicians, researchers, patients, and the general public concerning GVHD and late effects of transplants, their prevention, treatment and cure.
- Providing general information concerning the blood cancers and their treatment, with a special emphasis on the treatment of leukemia and bone marrow and stem cell transplantation.
- Providing resources to support programs designed to enhance the quality of life of patients and their families during treatment.
EXHIBITORS
The GVHD Alliance is empowering voices in the GVHD community to increase awareness and help improve the lives of people living with GVHD. The GVHD Alliance has developed a unified platform that facilitates a nurturing community for people living with GVHD, connecting resources, education, and support. Current GVHD Alliance member organizations include: American Society for Transplantation and Cellular Therapy (ASTCT), NMDP, Blood & Marrow Transplant Information Network (BMT InfoNet), Leukemia and Lymphoma Society (LLS), Meredith A. Cowden Foundation and National Bone Marrow Transplant Link (nbmtLINK). www.GVHDAlliance.org
Medexus Pharmaceutical Inc. is an innovative specialty & rare disease pharmaceutical company with a portfolio of products that address a variety of diseases, including allergy, dermatology, hematology, oncology, rheumatology and rare diseases. We provide innovative prescription and over the counter brands to patients and healthcare professionals, which we believe greatly enhances quality of life and promotes a healthy lifestyle. www.medexus.com
Driven by science and a passion for quality, STEMCELL Technologies offers over 2500 tools and services to support discoveries in fields such as regenerative medicine, immunotherapy, and disease research. Whether you’re culturing and editing hematopoietic stem and progenitor cells, differentiating pluripotent stem cells, or activating and expanding immune cells, we have specialized cell isolation products, high-performance cell culture media, and accessory tools for your research. By increasing the accessibility of innovative techniques like gene editing and organoid cultures, we’re helping scientists accelerate the pace of discovery—so they can get therapies to patients faster. Researchers working towards clinical trials can also obtain guidance and customized support through our Services for Cell Therapy Program on qualifying our products for use as raw/ancillary materials. To learn more, visit www.STEMCELL.com
SESSION TRAVEL
The American Society for Transplantation and Cellular Therapy (ASTCT®) is an international professional membership association. Our community of more than 3,900 members spans the full spectrum of the hematopoietic cell transplantation, cellular therapy and gene therapy field, and is inclusive of physicians, investigators, advanced practice professionals, pharmacists, transplant nurses and administrative staff. We strive to be the leading organization promoting research, education and clinical practice in the field.
Visit the ASTCT website to learn more about membership and our upcoming events.
Established in 1992, the International Society for Cell & Gene Therapy (ISCT) is a global society of clinicians, regulators, researchers, technologists, and industry partners with a shared vision to translate cell and gene therapy into safe and effective therapies to improve patients’ lives worldwide.
ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients. ISCT offers a unique collaborative environment that addresses three key areas of translation: Academia, Regulatory, and Commercialization. Through strong relationships with global regulatory agencies, academic institutions, and industry partners, ISCT drives the advancement of research into a standard of care.
Comprising over 4,000 cell and gene therapy experts across five geographic regions and representation from over 60 countries, ISCT members are part of a global community of peers, thought leaders, and organizations invested in cell and gene therapy translation. For more information about the society, key initiatives, and upcoming meetings, please visit https://isctglobal.org, @ISCTglobal.